135 related articles for article (PubMed ID: 9359028)
1. PP60c-src expression in osteoclasts from osteopetrotic children and in giant tumor cells.
Trubert CL; Bernard F; Hivroz C; Carlioz A; Fischer A; Cournot G
Eur J Histochem; 1997; 41(3):169-76. PubMed ID: 9359028
[TBL] [Abstract][Full Text] [Related]
2. Cells in vivo and in vitro from osteopetrotic mice homozygous for c-src disruption show suppression of synthesis of osteopontin, a multifunctional extracellular matrix protein.
Chackalaparampil I; Peri A; Nemir M; Mckee MD; Lin PH; Mukherjee BB; Mukherjee AB
Oncogene; 1996 Apr; 12(7):1457-67. PubMed ID: 8622862
[TBL] [Abstract][Full Text] [Related]
3. Osteoclasts express high levels of pp60c-src in association with intracellular membranes.
Horne WC; Neff L; Chatterjee D; Lomri A; Levy JB; Baron R
J Cell Biol; 1992 Nov; 119(4):1003-13. PubMed ID: 1385441
[TBL] [Abstract][Full Text] [Related]
4. An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: a mediator of osteoclast activity.
Lau KH; Wu LW; Sheng MH; Amoui M; Suhr SM; Baylink DJ
J Cell Biochem; 2006 Apr; 97(5):940-55. PubMed ID: 16267838
[TBL] [Abstract][Full Text] [Related]
5. Hormonal regulation of pp60c-src expression during osteoclast formation in vitro.
Yoneda T; Niewolna M; Lowe C; Izbicka E; Mundy GR
Mol Endocrinol; 1993 Oct; 7(10):1313-8. PubMed ID: 7505394
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the Src-cortactin pathway in podosome formation and turnover during polarization of cultured osteoclasts.
Luxenburg C; Parsons JT; Addadi L; Geiger B
J Cell Sci; 2006 Dec; 119(Pt 23):4878-88. PubMed ID: 17105771
[TBL] [Abstract][Full Text] [Related]
7. Increased immunoreactivity and protein tyrosine kinase activity of the protooncogene pp60c-src in preneoplastic lesions in rat pancreas.
Visser CJ; Rijksen G; Woutersen RA; De Weger RA
Lab Invest; 1996 Jan; 74(1):2-11. PubMed ID: 8569183
[TBL] [Abstract][Full Text] [Related]
8. Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.
Gouin F; Couillaud S; Cottrel M; Godard A; Passuti N; Heymann D
Cytokine; 1999 Apr; 11(4):282-9. PubMed ID: 10328867
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of pp60c-src in low grade human bladder carcinoma.
Fanning P; Bulovas K; Saini KS; Libertino JA; Joyce AD; Summerhayes IC
Cancer Res; 1992 Mar; 52(6):1457-62. PubMed ID: 1371716
[TBL] [Abstract][Full Text] [Related]
10. Regulation of collagenolytic protease secretion through c-Src in osteoclasts.
Furuyama N; Fujisawa Y
Biochem Biophys Res Commun; 2000 May; 272(1):116-24. PubMed ID: 10872813
[TBL] [Abstract][Full Text] [Related]
11. Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts.
Insogna KL; Sahni M; Grey AB; Tanaka S; Horne WC; Neff L; Mitnick M; Levy JB; Baron R
J Clin Invest; 1997 Nov; 100(10):2476-85. PubMed ID: 9366562
[TBL] [Abstract][Full Text] [Related]
12. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis.
Bjelfman C; Hedborg F; Johansson I; Nordenskjöld M; Påhlman S
Cancer Res; 1990 Nov; 50(21):6908-14. PubMed ID: 1698545
[TBL] [Abstract][Full Text] [Related]
13. Invasion of epithelial cells by Shigella flexneri induces tyrosine phosphorylation of cortactin by a pp60c-src-mediated signalling pathway.
Dehio C; Prévost MC; Sansonetti PJ
EMBO J; 1995 Jun; 14(11):2471-82. PubMed ID: 7540134
[TBL] [Abstract][Full Text] [Related]
14. Coordinate alteration of pp60c-src abundance and c-src RNA expression in human neuroblastoma variants.
Veillette A; O'Shaughnessy J; Horak ID; Israel MA; Yee D; Rosen N; Fujita DJ; Kung HJ; Biedler JL; Bolen JB
Oncogene; 1989 Apr; 4(4):421-7. PubMed ID: 2470006
[TBL] [Abstract][Full Text] [Related]
15. pp60c-src activation in hepatocellular carcinoma of humans and LEC rats.
Masaki T; Okada M; Shiratori Y; Rengifo W; Matsumoto K; Maeda S; Kato N; Kanai F; Komatsu Y; Nishioka M; Omata M
Hepatology; 1998 May; 27(5):1257-64. PubMed ID: 9581679
[TBL] [Abstract][Full Text] [Related]
16. Site-specific differences in pp60c-src activity in human colorectal metastases.
Termuhlen PM; Curley SA; Talamonti MS; Saboorian MH; Gallick GE
J Surg Res; 1993 Apr; 54(4):293-8. PubMed ID: 7687314
[TBL] [Abstract][Full Text] [Related]
17. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice.
Boyce BF; Yoneda T; Lowe C; Soriano P; Mundy GR
J Clin Invest; 1992 Oct; 90(4):1622-7. PubMed ID: 1383278
[TBL] [Abstract][Full Text] [Related]
18. Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis.
Flanagan AM; Sarma U; Steward CG; Vellodi A; Horton MA
J Bone Miner Res; 2000 Feb; 15(2):352-60. PubMed ID: 10703938
[TBL] [Abstract][Full Text] [Related]
19. Activity of pp60c-src in 60 different cell lines derived from human tumors.
Budde RJ; Ke S; Levin VA
Cancer Biochem Biophys; 1994 Oct; 14(3):171-5. PubMed ID: 7537173
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
Karni R; Jove R; Levitzki A
Oncogene; 1999 Aug; 18(33):4654-62. PubMed ID: 10467412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
